NASDAQ
2.91USD
-0.12 (-3.89%)
We have scored 4 news catalysts on DataMEDS AI, Inc. (MEDS) over the past 12 months. The biggest single-day move next to one of them came Sep 16, 2026, when MEDS closed +274.7%: “Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket”. Coverage across the window leans positive (average ticker sentiment +0.80). Most of the impact sits in short squeeze potential and revenue growth rate.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
7.6M
P/E
—
EPS
—
Beta
-1.52
52W range
0.8225-73
Day range
2.80–2.99
Open
2.89
Prev close
3.03
Volume
342.6K
Avg volume
4.5M
Dividend
0.00
IPO
2025-02-21
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about DataMEDS AI, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for MEDS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
